Newsletter of MEDICA | View in browser | Deutsch | Print
Header of MEDICA Newsletter

Medical teaching in virtual reality: more practice, less risk

Dear Sir or Madam,

Students train realistic emergencies in virtual reality, while researchers analyze the benefits for examinations and decision-making. Simulations enable practical learning situations - without the need for acting patients.

Enjoy reading!

Tim Plato
Editorial team MEDICA-tradefair.com

P.S.: Researchers are testing how cultured mini-tumors could improve the treatment of pancreatic cancer. These organoids could help to develop more effective treatments and reduce resistance.

Table of Contents
Multimedia report: Virtual reality in medical education
Interview: Organoids improve cancer therapy
Newsletter Service

What are the advantages of VR-based examinations in medical training?
Image: A graphic with the text: 750€ ... saved by VR training per semester compared to physical stations; Copyright:UKW/THREEDEE
Further advantages are:
• 93 percent of students were able to use VR technology without any problems.
• 53 of 57 VR data sets could be included without technical problems.
To top

Virtual reality in medical education

Multimedia report – DIGITAL HEALTH
Image: Robotic-assisted laser procedure during surgical intervention on the spinal cord; Copyright: Fraunhofer ILT, Aachen / Ralf Baumgarten
How is virtual reality changing medical training? Find out how students train with realistic simulations and what advantages this offers in practice!
Click here for the multimedia report
Virtual reality makes emergency training more realistic and supports practical examinations!
Image: Banner with the text: DIGITAL HEALTH in the MEDICA-Magazine; Copyright: Messe Düsseldorf
To top

New digital therapy platform for rheumatism patients

News

DIGITAL HEALTH
Around 245,000 people in Lower Saxony suffer from rheumatism. Many of them are of working age, and due to their condition, some face significant limitations in their professional and personal lives. The high costs of medication further underscore the need for treatment solutions. The RELIEV project, developed by Hannover Medical School aims to bridge this gap through a digital therapy platform.
read more
To top

Organoids to improve treatment outcomes for pancreatic cancer

Interview – LAB & DIAGNOSTICS
Image: Model of a pancreas with a pin pointing to a cancerous tumor
How can organoids improve cancer therapy? Find out how researchers are testing new treatment approaches with mini-tumors!
Click here for the interview
Organoids help to develop more effective therapies and reduce resistance!
Discover more from the LAB & DIAGNOSTICS sphere
To top

New blood test improves early detection of pancreatic cancer

News

LAB & DIAGNOSTICS
A newly developed blood test could help doctors detect pancreatic cancer earlier, significantly improving survival rates for one of the most lethal cancers. The test, called PAC-MANN, was created by researchers at Oregon Health & Science University (OHSU) and has demonstrated an 85 percent accuracy rate in identifying early-stage pancreatic cancer.
read more
To top

Newsletter Service

You like our newsletter? Then please recommend us: Forward this newsletter or the link www.MEDICA.de/news_login_2 to your friends and colleagues.

If you have difficulties with your order, please write an e-mail to medica-redaktion@messe-duesseldorf.de.
To top
Legal disclaimer

Messe Düsseldorf GmbH
Messeplatz, Stockumer Kirchstr. 61
40474 Düsseldorf, Germany

Phone: +49 211 4560-01
Fax: +49 211 4560-668
www.messe-duesseldorf.de
info@messe-duesseldorf.de

County Court Düsseldorf HRB 63

Board of Managing Directors: Wolfram N. Diener (Chairman), Marius Berlemann, Bernhard J. Stempfle

Chairman of Supervisory Board: Mayor Dr. Stephan Keller

Messe Düsseldorf GmbH processes personal data relating to you. You can find more information - also on your rights - in the privacy policy of Messe Düsseldorf GmbH available at www.messe-duesseldorf.de/privacy. In principle, i.e. subject to legal restrictions, you may at any time object to the processing of your personal data either on the aforementioned website, via e-mail to privacy@messe-duesseldorf.de or via postal mail to Messe Düsseldorf GmbH, G2-RV, PF 101006, 40001 Düsseldorf, Germany.

Facebook LinkedIn YouTube

Should you no longer wish to receive our newsletter, please click here.